Research and development of gas sensors and new products
First written in FY2016. 18 of 37 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「Research and development staff account for 11.4% of total employees, while research and development expenses for the fiscal year were ¥2,733 million, equivalent to 5.0% of net sales.」
Research and development expenses increased from ¥2,544.74 million in the previous fiscal year to ¥2,733.20 million, with specific results including GD-81D, toxic gas sensors, certified sensors and systems for RTGMS. - 2026-05-29AdvancedGeneral Meeting of Shareholders
「今後、実証実験を行い、2027年秋に量産試作を開始予定です。そして、国際的な安全指標を満たした上で2028年の夏に市場での販売を目指しています。」
研究開発について、アンモニアガス漏洩可視化システムの実証実験から量産試作、市場販売までの具体的な予定を示している。 - FY2026-H1Updated interim R&D expensesAnnual report
「The amount spent on R&D activities by the Group as a whole during the current interim consolidated accounting period was ¥1.376 billion. There were no material changes in the status of the Group's R&D activities during the current interim consolidated accounting period.」
Research and development expenses for the interim consolidated accounting period were ¥1,376 million, and there were no material changes in research and development activities. - FY2025AdvancedAnnual report
「The Group's R&D is conducted by the company's Technology Development Headquarters. R&D staff account for 15.1% of total employees, and R&D expenses for the current consolidated fiscal year were ¥2.544 billion, or 5.2% of net sales.」
The company reported R&D expenses of ¥2.54474 billion, or 5.2% of net sales, with R&D staff accounting for 15.1% of total employees, and demonstrated results including GX-6100, FPM-80A, certified sensors, and SDM-230. - FY2025-H1Updated interim R&D expensesAnnual report
「The amount spent on R&D activities by the Group as a whole during the current interim consolidated accounting period was ¥1.184 billion. There were no material changes in the status of the Group's R&D activities during the current interim consolidated accounting period.」
R&D expenses for the current interim consolidated accounting period were ¥1.184 billion, and the company stated that there were no material changes in the status of its R&D activities. - FY2024AdvancedAnnual report
「The Group's R&D is conducted by the company's Technology Development Headquarters. R&D staff account for 14.9% of total employees, and R&D expenses for the current consolidated fiscal year were ¥2.288 billion, or 5.0% of net sales.」
The company reported that R&D staff accounted for 14.9% of total employees and R&D expenses were ¥2.28893 billion, or 5.0% of net sales, and demonstrated specific results including the SP-230, FPM-80, sensors for the GX-9000 series, and sensors for RTGMS. - FY2024-Q3Updated third-quarter R&D expensesAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter of the current consolidated fiscal year was ¥1.775 billion. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative third quarter were ¥1.775 billion, and the company stated that there were no material changes in the status of its R&D activities. - FY2024-Q2Updated second-quarter research and development expensesAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative second quarter of the current consolidated fiscal year was ¥1.156 billion. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative second quarter were ¥1.156 billion, and the company stated that there were no material changes in the status of its R&D activities. - FY2024-Q1Updated first-quarter R&D expensesAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter of the current consolidated fiscal year was ¥585 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenses in FY2024-Q1 were ¥585 million, and the company stated that there were no material changes in the status of its R&D activities. - FY2023AdvancedAnnual report
「The Group's R&D is conducted by the company's Technology Development Headquarters. R&D staff account for 15.4% of total employees, and R&D expenses for the current consolidated fiscal year were ¥2.408 billion, or 5.4% of net sales.」
The company reported R&D expenses of ¥2.4085 billion, or 5.4% of net sales, with R&D staff accounting for 15.4% of total employees, and developed the 9000 series, GX-Force, several new sensors, and semi-custom systems related to decarbonization. - FY2023-Q3Updated third-quarter R&D expensesAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter of the current consolidated fiscal year was ¥1.752 billion. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative third quarter were ¥1.752 billion, and the company stated that there were no material changes in the status of its R&D activities. - FY2023-Q2Updated second-quarter research and development expensesAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative second quarter of the current consolidated fiscal year was ¥1.197 billion. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative second quarter were ¥1.197 billion, and the company stated that there were no material changes in the status of its R&D activities. - FY2023-Q1Updated first-quarter R&D expensesAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter of the current consolidated fiscal year was ¥575 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative first quarter were ¥575 million, and the company stated that there were no material changes in the status of its R&D activities. - FY2022-Q3RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter of the current consolidated fiscal year was ¥1.458 billion. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative third quarter were ¥1.458 billion, and the company stated that there were no material changes in the status of its R&D activities. - FY2022-Q2RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative second quarter of the current consolidated fiscal year was ¥994 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative second quarter were ¥994.059 million, and the company stated that there were no material changes in the status of its R&D activities. - FY2022-Q1RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter of the current consolidated fiscal year was ¥508 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative first quarter were ¥508 million, and the company stated that there were no material changes in the status of its R&D activities. - FY2021AdvancedAnnual report
「The Group's R&D is conducted by the company's Technology Development Headquarters. R&D staff account for 15.4% of total employees, and R&D expenses for the current consolidated fiscal year were ¥1.908 billion, or 5.9% of net sales.」
R&D expenses were ¥1.908 billion, or 5.9% of net sales, and R&D staff accounted for 15.4% of total employees. The company also reported specific results, including TR-L1, FI-900, and various toxic-gas sensors. - FY2021-Q3RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter of the current consolidated fiscal year was ¥1.453 billion. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative third quarter were ¥1.453 billion, and the company stated that there were no material changes in the status of its R&D activities. - FY2021-Q2RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative second quarter of the current consolidated fiscal year was ¥942 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
The company reported R&D expenses of ¥942 million for the cumulative second quarter and stated that there were no material changes in the status of its R&D activities. - FY2021-Q1RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter of the current consolidated fiscal year was ¥431 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenses for the first quarter were ¥431 million, and the company stated that there were no material changes in the status of its R&D activities. - FY2020AdvancedAnnual report
「The Group's R&D is led primarily by the company's Technology Development Headquarters. R&D staff account for 16.4% of total employees, and R&D expenses for the current consolidated fiscal year were ¥1.754 billion, or 5.5% of net sales.」
The company reported that R&D staff accounted for 16.4% of total employees and R&D expenses were ¥1.75457 billion, or 5.5% of net sales, and developed several new products and sensors. - FY2020-Q3RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter of the current consolidated fiscal year was ¥1.332 billion. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative third quarter were ¥1.332 billion, and the company stated that there were no material changes in the status of its R&D activities. - FY2020-Q2RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative second quarter of the current consolidated fiscal year was ¥894 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative second quarter were ¥894 million, and the company stated that there were no material changes in the status of its R&D activities. - FY2020-Q1RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter of the current consolidated fiscal year was ¥448 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative first quarter were ¥448 million, and the company stated that there were no material changes in the status of its R&D activities. - FY2019AdvancedAnnual report
「The Group's R&D is led primarily by the company's Technology Development Headquarters. R&D staff account for 16.8% of total employees, and R&D expenses for the current consolidated fiscal year were ¥1.883 billion, or 6.1% of net sales.」
The company reported that R&D staff accounted for 16.8% of total employees and R&D expenses were ¥1.883 billion, or 6.1% of net sales, and developed several new products and sensors. - FY2019-Q3RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter of the current consolidated fiscal year was ¥1.419 billion. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative third quarter were ¥1.419 billion, and the company stated that there were no material changes in the status of its R&D activities. - FY2019-Q2RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative second quarter of the current consolidated fiscal year was ¥997 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
R&D expenses for the cumulative second quarter were ¥997 million, and the company stated that there were no material changes in the status of its R&D activities. - FY2019-Q1RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter of the current consolidated fiscal year was ¥513 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
R&D expenses for the first quarter were ¥513 million, and the company stated that there were no material changes in the status of its R&D activities. - FY2018AdvancedAnnual report
「The Group's R&D is led primarily by the company's Technology Development Headquarters. R&D staff account for 17.0% of total employees, and R&D expenses for the current consolidated fiscal year were ¥1.808 billion, or 6.4% of net sales.」
The company reported that R&D staff accounted for 17.0% of total employees and R&D expenses were ¥1.808 billion, or 6.4% of net sales, and developed several new products and sensors. - FY2018-Q3RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter of the current consolidated fiscal year was ¥1.291 billion. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
The company stated that there were no material changes in the status of its R&D activities and reported R&D expenses of ¥1.291 billion for the cumulative third quarter of the current consolidated fiscal year. - FY2018-Q2RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative second quarter of the current consolidated fiscal year was ¥845 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
The company stated that there were no material changes in the status of its R&D activities and reported R&D expenses of ¥845 million for the cumulative second quarter of the current consolidated fiscal year. - FY2018-Q1RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter of the current consolidated fiscal year was ¥420 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
The company stated that there were no material changes in the status of its R&D activities and reported R&D expenses of ¥420 million for the cumulative first quarter of the current consolidated fiscal year. - FY2017AdvancedAnnual report
「R&D expenses for the current consolidated fiscal year were ¥1.438 billion, or 6.2% of net sales.」
Although the quarterly disclosures stated that there had been no material changes in R&D activities, the company developed several new products during the year and recorded R&D expenses of ¥1.438 billion, or 6.2% of net sales. - FY2017-Q3RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter of the current consolidated fiscal year was ¥1.049 billion. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter of the current consolidated fiscal year.」
There were no material changes in R&D activities, and R&D expenses for the cumulative third quarter were ¥1.049 billion. - FY2017-Q2RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative second quarter of the current consolidated fiscal year was ¥717 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter of the current consolidated fiscal year.」
There were no material changes in R&D activities, and R&D expenses for the cumulative second quarter were ¥717 million. - FY2017-Q1RestatedAnnual report
「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter of the current consolidated fiscal year was ¥343 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter of the current consolidated fiscal year.」
There were no material changes in R&D activities, and R&D expenses for the cumulative first quarter were ¥343 million. - FY2016First statedAnnual report
「Research and development of higher-functionality gas sensors, including new measurement principles, expanded target gases, and intelligent features; development of products and systems to prevent industrial accidents, including gas explosions, gas poisoning, and oxygen deficiency; development of products and systems to prevent environmental pollution and public nuisance; development of products for new markets using various sensors; and development of products for new fields incorporating new technologies and various software.」
R&D staff account for 15.8% of total employees, while R&D expenses were ¥1.435 billion, or 6.1% of net sales.